How effective is the personalized off-label use of targeted cancer treatment?

The article from Nature (2026) investigates the effectiveness of using tumour-type-specific therapies for cancers with genetic changes in targeted pathways when standard treatments fail. It questions the success rate of personalized off-label cancer treatments.